Abstracts tagged "Asian-Americans"

Abstract Number: 1142 • 2017 ACR/ARHP Annual Meeting
A Case Control Study of Anakinra Use for Acute Gout in a VA Patient Cohort Reveals Association with East Asian Descent, High Urate Burden, and Increased Co-Morbidities and All-Cause Mortality
Ena Sharma¹ and Robert Terkeltaub², ¹Rheumatology, University Of California San Diego, San Diego, CA, ²Rheumatology, VA San Diego Healthcare System, San Diego, CA
Background/Purpose: Effectiveness of the IL-1 receptor antagonist anakinra, in resolving flares of acute gout, has been reported in several case series. Here, studying a VA…
Abstract Number: 1260 • 2016 ACR/ARHP Annual Meeting
Association of Traditional Chinese Medicine Use and Adherence to Prescribed Western Medications in Chinese-American Rheumatology Patients
Kai Sun¹, Henghe Tian², Yuo-Yu Lee³, Jennifer Leng⁴ and Lisa Mandl⁵, ¹Internal Medicine, Hospital for Special Surgery, New York, NY, ²Internal Medicine, New York University School of Medicine, New York, NY, ³Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, ⁴Immigrant Health and Cancer Disparities laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, ⁵Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Chinese-Americans are one of the fastest growing immigrant groups in the US. They often use Traditional Chinese Medicine (TCM), but whether that affects medication…
Abstract Number: 748 • 2015 ACR/ARHP Annual Meeting
Comparison of Systemic Lupus Erythematosus in 3 Different Asian Ethnic Groups: Results from the 1000 Faces of Lupus Cohort
Mai Nguyen¹, Earl Silverman², Janet E. Pope³, Paul R. Fortin⁴, Ann E. Clarke⁵, Christian Pineau⁶, Sasha R Bernatsky⁷, C Douglas Smith⁸, Gaëlle Chédeville⁹, Lori B. Tucker¹⁰, Michel Zummer¹¹, Marie Hudson⁶, Adam M. Huber¹², Deborah M. Levy¹³, Hector Arbillaga¹⁴, Carol Hitchon¹⁵, Christine A. Peschken¹⁶ and CaNIOS 1000 Faces Investigators, ¹Medicine, University of Manitoba, Winnipeg, MB, Canada, ²Division of Rheumatology, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ³University of Western Ontario, London, ON, Canada, ⁴Medicine, CHU de Québec - Université Laval, Québec, QC, Canada, ⁵Immunology/Epidemiology, Montreal General Hospital, Montreal, QC, Canada, ⁶Medicine, McGill University, Montreal, QC, Canada, ⁷Division of Rheumatolog, McGill Unversity Health Cener, Montreal, QC, Canada, ⁸The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁹Rheumatology, McGill University, Montreal, QC, Canada, ¹⁰Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, ¹¹Rheumatology, Hôpital Maisonneuve-Rosemont and University of Montreal, Montreal, QC, Canada, ¹²Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, ¹³Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁴Calgary Rheumatology, Calgary, AB, Canada, ¹⁵University of Manitoba, Winnipeg, MB, Canada, ¹⁶Rheumatology, Univ of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Ethnic variations in systemic lupus erythematosus (SLE) are well described, with more prevalent and severe disease in non-Caucasians including North American Asians. However, Asian…
Abstract Number: 1193 • 2015 ACR/ARHP Annual Meeting
The Effectiveness of Low-Impact Exercise Program on Musculoskeletal Health of Asian Older Adults
Huijuan Huang¹, Titilayo Ologhobo¹, Vicky Jin¹, Sandra Goldsmith² and Laura Robbins¹, ¹Education & Academic Affairs, Hospital for Special Surgery, New York, NY, ²Public and Patient Education, Hospital for Special Surgery, New York, NY
Background/Purpose: The Center for Disease Control and Prevention (CDC) showed that in 2010-2015, 50% of adults 65 years or older reported an arthritis diagnosis. Studies…
Abstract Number: 988 • 2013 ACR/ARHP Annual Meeting
Lupus Education For Providers Serving The Asian American Community: Hospital For Special Surgery’s LANtern® (Lupus Asian Network) Initiative
My-Lan N. Tran¹, Roberta Horton², Michael D. Lockshin³ and Arthur Yee⁴, ¹Social Work Programs, Hospital for Special Surgery, New York City, NY, ²Department of Social Work Programs, Hospital for Special Surgery, New York, NY, ³Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ⁴Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Lupus affects Asian Americans 2-3 times more than their white counterparts, with studies demonstrating health disparities in severity and outcomes. Our hospital’s national support…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].